← Browse by Condition
Medical Condition

unresectable colon cancer peritoneal metastases

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05742425 Phase 2
Recruiting

Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases

Enrollment
30 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →